Pharming Group N.V.
PHAR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828316
No open-market purchases or sales by Pharming Group N.V. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $1.31M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Pharming Group N.V. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 13 | 16 | +3 |
| Shares | 85.8K | 95.2K | +9.40K (+11.0%) |
| Value | $1.43M | $1.31M | −$113.6K (−8.0%) |
New holders (6)
Institutions that held Pharming Group N.V. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Crossmark Global Holdings, Inc. | 12,463 | $169.0K | 0.00% |
| Silver Grove Financial Group, Inc. | 1,071 | $14.9K | 0.01% |
| Global Retirement Partners, LLC | 456 | $6.33K | 0.00% |
| Optiver Holding B.V. | 305 | $4.14K | 0.00% |
| UBS Group AG | 39 | $542 | 0.00% |
| Caitong International Asset Management Co., Ltd | 1 | $14 | 0.00% |
Sold out (3)
Institutions that held Pharming Group N.V. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| EverSource Wealth Advisors, LLC | 557 | $9.27K |
| Stone House Investment Management, LLC | 79 | $1.31K |
| Cornerstone Financial Management LLC | 32 | $532 |